Evidence map›Paper›PMID 29262849›Full record

ReviewGlobalization and health2017

Non-communicable diseases control in China and Japan.

Fei Wu, Hiroto Narimatsu, Xiaoqiang Li, Sho Nakamura, Ri Sho, Genming Zhao, Yoshinori Nakata, Wanghong Xu

Open access · goldAbstract readComparative StudyReview
In one paragraph

Review in Globalization and health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Role and molecular mechanism of NOD2 in chronic non-communicable diseases.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Fei WuDepartment of Epidemiology, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, People's Republic of China.
Hiroto NarimatsuCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, 2-2-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan.
Xiaoqiang LiDepartment of Epidemiology, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, People's Republic of China.
Sho NakamuraCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, 2-2-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan.
Ri ShoDepartment of Public Health, Graduate School of Medical Science, Yamagata University, 2-2-2, Iida-nishi, Yamagata, 990-9585, Japan.
Genming ZhaoDepartment of Epidemiology, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, People's Republic of China.
Yoshinori NakataGraduate School of Public Health, Teikyo University, 2-11-1 Kaga Itabashi-ku, Tokyo, 1738605, Japan.
Wanghong XuDepartment of Epidemiology, School of Public Health, Fudan University, 138 Yi Xue Yuan Road, Shanghai, 200032, People's Republic of China. wanghong.xu@fudan.edu.cn.ORCID http://orcid.org/0000-0003-2045-2218
Fudan University · CNYamagata University · JPKanagawa Prefectural Hospital Organization · JPTeikyo University · JP

Funding

the Consulting Service for Center of Excellence in Global Health Policy Development and Governance in China GHSP-CS-OP3-02the National Key R & D Program of China 2017YFC09070000the Three-year Action Plan on Public Health, Phase IV, Shanghai, China 15GWZK0801
6 · The paper itself

Abstract

China and Japan share numerous similarities other than their geographical proximity. Facing the great challenges of non-communicable diseases (NCDs), China and Japan have developed different preventive strategies and systems. While Japan has made great progress in primary prevention of NCDs through strong legislation, the 'Specific Health Check and Guidance System' and a unique licensed health professional system, China is attempting to catch up by changing its strategies in NCDs control. In this manuscript, we compared disease burden of NCDs, health care systems and preventive strategies against NCDs between China and Japan. In this light, we summarized the points that the two countries can learn from each other, and proposed recommendations for the two countries in NCDs control.

Indexed as

ChinaCost of IllnessDelivery of Health CareHumansJapanNoncommunicable DiseasesComparisonNon-communicable diseasesPreventive strategies

Identifiers

PMID29262849
PMCPMC5738724
OpenAlexW2781373451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.